Michael Forster
Group Leader of Liquid Biomarkers
+49 431 / 500 - 15 136
Research Group
Research Interest
Our vision is to utilise molecular profiling to detect disease at an early stage, for example early-stage cancer when it can be resected, and to guide individualised therapy. Body fluids hold great promise for our future research and clinical translation, as they permit insights into molecular profiles and their changes over the course of time or in response to a therapy, in a completely non-invasive or minimally-invasive manner.